Emerging high-throughput drug target validation technologies

Drug Discovery Today

Volumn 7, Issue 18, 2002, Pages S136-S142

  Ilag, Leodevico L ^a   Ng, Jocelyn H ^a   Beste, Gerald ^a   Henning, Stefan W ^a  

^a Xerion Pharmaceuticals   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTISENSE OLIGONUCLEOTIDE; APTAMER; COMPLEMENTARY RNA; GENE PRODUCT; PEPTIDE; RIBOZYME;

CHEMICAL GENETICS; CHROMATOPHORE; CORRELATION ANALYSIS; DNA MICROARRAY; DRUG TARGETING; GENE SILENCING; GENE THERAPY; GENOME ANALYSIS; HUMAN; LASER; MOLECULAR CLONING; MOLECULAR GENETICS; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN PROCESSING; REVIEW; RNA INTERFERENCE; RNA PROCESSING; RNA SPLICING; RNA TRANSCRIPTION; VALIDATION PROCESS;

BIOTECHNOLOGY; DRUG EVALUATION, PRECLINICAL; DRUG INDUSTRY; GENOMICS; PHENOTYPE; PROTEINS; REPRODUCIBILITY OF RESULTS; ROBOTICS;

EID: 0037107004     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(02)02429-7     Document Type: Review

References (46)

1. Flanagan, A. et al. (2002) A Revolution in R&D: How genomics and genetics are transforming the biopharmaceutical industry. Boston Consulting Group Report 26 November, 1-64 (available online at: http://www.bcg.com/publications/files/eng_genomicsgenetics_rep_11_01.pdf)
2. Jeffery C.J. Moonlighting proteins. Trends Biochem. Sci. 24:1999;8-11.
3. Botstein D., Maurer R. Genetic approaches to the analysis of microbial development. Ann. Rev. Genet. 16:1982;61-83.
4. Beger C., et al. Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach. Proc. Natl. Acad. Sci. U. S. A. 98:2001;130-135.
5. Krauledat P.B., Hansen W.P. Automated testing of model organisms. Genetic Engineering News. 21:2001;1-3.
6. Geusebroek J-M., et al. Robust autofocusing in microscopy. Cytometry. 36:2000;1-9.
7. Lorens J.B., et al. The use of retroviruses as pharmaceutical tools for target discovery and validation in the field of functional genomics. Curr. Opin. Biotechnol. 12:2001;613-621.
8. Holland S.J., et al. Functional cloning of Src-like adapter protein-2 (SLAP-2), a novel inhibitor of antigen receptor signalling. J. Exp. Med. 194:2001;1263-1276.
9. Koller D., et al. A high-throughput alphavirus-based expression cloning system for mammalian cells. Nature Biotechnol. 19:2001;851-855.
10. Lilley C.E., et al. Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo. J. Virol. 75:2001;4343-4356.
11. Grimm S., Kachel V. Robotic high-throughput assay for isolating apoptosis-inducing genes. BioTechniques. 32:2002;670-677.
12. Neudecker F., Grimm S. High-throughput method for isolating plasmid DNA with reduced lipopolysaccharide content. BioTechniques. 28:2000;108-110.
13. Welch P.J., et al. Identification and validation of a gene involved in anchorage-independent cell growth control using a library of randomized hairpin ribozymes. Genomics. 66:2000;274-283.
14. Kawasaki H., et al. Identification of genes that function in the TNF-α-mediated apoptotic pathway using randomised hybrid ribozyme libraries. Nat. Biotechnol. 20:2002;376-380.
15. Li Q.X., et al. A novel functional genomics approach identified mTERT as a suppressor of fibroblast transformation. Nucleic Acids Res. 28:2000;2605-2612.
16. Dean N.M. Functional genomics and target validation approaches using antisense oligonucleotide technology. Curr. Opin. Biotechnol. 12:2001;622-625.
17. Heasman J. Morpholino oligos: making sense of antisense? Dev. Biol. 243:2002;209-214.
18. Ando H., et al. Photo-mediated gene activation using caged RNA/DNA in zebrafish embryos. Nat. Genet. 28:2001;317-325.
19. Fjose A., et al. RNA interference: mechanisms and applications. Biotechnol. Annu. Rev. 7:2001;31-57.
20. Zhao Z., et al. Double-stranded RNA injection produces non-specific defects in zebrafish. Dev. Biol. 229:2001;215-223.
21. Elbashir S.M., et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature. 411:2001;494-498.
22. Brummelkamp T.R., et al. A system for stable expression of short interfering RNAs in mammalian cells. Science. 296:2002;550-553.
23. Paul C.P., et al. Effective expression of small interfering RNA in human cells. Nat. Biotechnol. 20:2002;505-508.
24. Dove A. Antisense and sensibility. Nat. Biotechnol. 20:2002;121-124.
25. Drews J. Drug discovery: a historical perspective. Science. 17:2000;5460-5464.
26. Morris M.C., et al. A peptide carrier for the delivery of biologically active proteins into mammalian cells. Nat. Biotechnol. 19:2001;1173-1176.
27. Auf der Maur A., et al. Antigen-independent selection of stable intracellular single-chain antibodies. FEBS Lett. 508:2001;407-412.
28. Muller B.K., Bonhoeffer F. Molecular inactivation. Spatially and temporally defined molecular knockouts. Curr. Biol. 5:1995;1255-1256.
29. Tuerck C. Using the SELEX combinatorial chemistry process to find high affinity nucleic acid ligands to target molecules. Methods Mol. Biol. 67:1997;219-230.
30. Cox J.C., et al. Automated RNA selection. Biotechnol. Prog. 14:1998;845-850.
31. Shi H., et al. RNA aptamers as effective protein antagonists in a multicellular organism. Proc. Natl. Acad. Sci. U. S. A. 96:1999;10033-10038.
32. Famulok M., et al. Intramers as promising new tools in functional proteomics. Chem. Biol. 8:2001;931-939.
33. Kay B., et al. From peptides to drugs via phage display. Drug Discov. Today. 3:1998;370-378.
34. Caponigro G., et al. Transdominant genetic analysis of a growth control pathway. Proc. Natl. Acad. Sci. U. S. A. 95:1998;7508-7513.
35. Xu X., et al. Dominant effector genetics in mammalian cells. Nat. Genet. 27:2001;23-29.
36. Schreiber S.L. Target-oriented and diversity-oriented organic synthesis in drug discovery. Science. 287:2000;1964-1969.
37. Lenz G.R., et al. Chemical ligands, genomics and drug discovery. Drug Discov. Today. 5:2000;145-156.
38. Brizuela L., et al. FLEXGene repository: from sequenced genomes to gene repositories for high-throughput functional biology and proteomics. Mol. Biochem. Parasitol. 118:2001;155-165.
39. Braun P., et al. Proteome-scale purification of human proteins from bacteria. Proc. Natl. Acad. Sci. U. S. A. 99:2002;2654-2659.
40. Martzen M.R., et al. A biochemical genomics approach for identifying genes by the activity of their products. Science. 286:1999;1153-1155.
41. Zhu H., et al. Global analysis of protein activities using proteome chips. Science. 29:2001;2101-2105.
42. MacBeath G., Schreiber S.L. Printing proteins as microarrays for high-throughput function determination. Science. 289:2000;1760-1763.
43. Fang Y., et al. Membrane protein arrays. J. Am. Chem. Soc. 124:2002;2394-2395.
44. Ilag L.L., et al. Chromophore-assisted laser inactivation (CALI) to validate drug targets and pharmacogenomic markers. Drug Dev. Res. 49:2000;65-73.
45. Beck S., et al. Fluorophore-assisted light inactivation: a high-throughput tool for direct target validation of proteins. Proteomics. 2:2002;247-255.
46. Rubenwolf S., et al. Functional proteomics using chromophore-assisted laser inactivation. Proteomics. 2:2002;241-246.